Correlation Between X4 Pharmaceuticals and Sangamo Therapeutics
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Sangamo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Sangamo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Sangamo Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and Sangamo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Sangamo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Sangamo Therapeutics.
Diversification Opportunities for X4 Pharmaceuticals and Sangamo Therapeutics
-0.53 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between XFOR and Sangamo is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Sangamo Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sangamo Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Sangamo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sangamo Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Sangamo Therapeutics go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Sangamo Therapeutics
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to under-perform the Sangamo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, X4 Pharmaceuticals is 1.16 times less risky than Sangamo Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Sangamo Therapeutics is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 365.00 in Sangamo Therapeutics on August 23, 2024 and sell it today you would lose (169.00) from holding Sangamo Therapeutics or give up 46.3% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Sangamo Therapeutics
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Sangamo Therapeutics |
X4 Pharmaceuticals and Sangamo Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Sangamo Therapeutics
The main advantage of trading using opposite X4 Pharmaceuticals and Sangamo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Sangamo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sangamo Therapeutics will offset losses from the drop in Sangamo Therapeutics' long position.| X4 Pharmaceuticals vs. Kiora Pharmaceuticals | X4 Pharmaceuticals vs. ZyVersa Therapeutics | X4 Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | X4 Pharmaceuticals vs. Zura Bio Limited |
| Sangamo Therapeutics vs. Editas Medicine | Sangamo Therapeutics vs. Intellia Therapeutics | Sangamo Therapeutics vs. Bluebird bio | Sangamo Therapeutics vs. Alnylam Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |